Thanks, Scott, and good afternoon, everyone. Since this is the first opportunity we have to talk about our recent capital markets activity, I'll begin my remarks by providing some context for both our recent equity raise and credit agreement amendment. After that, I'll provide an overview of our second quarter results and end with an update on our 2023 outlook. As Scott mentioned, when we went public last August, we did so with a two part strategy; first, we wanted to expand our flavors, extracts and ingredients platform to the build out of our Conway extract and RTD facility and, second, we wanted to expand internationally with our blue chip customer base. Our go-public transaction was designed to provide us with all the capital we needed to jumpstart that plan. As we began 2023, a few things became apparent. First, customer demand for the products we plan to produce out of our Conway facility exceeded our expectations, both in terms of volume and in the variety of formats our customers wanted. Second, this customer demand and the opportunities that presented were growing faster than our ability to access the capital we needed to fund them under the terms of our existing credit facility. And third, the overall US macroeconomic picture with higher inflation, higher interest rates and the turmoil in the banking sector, created uncertainty around expectations for consumer demand and 2023. Collectively, these factors led us to conclude we needed to build a fortress around our balance sheet to ensure we have the capital necessary to fund the expanded opportunities we were seeing out of our Conway extract and RTD facility, and to take advantage of any other opportunities that arose along the way. To accomplish this goal, we look to our lending syndicate to adjust our covenant package, while at the same time we sought to raise 100 million in equity we could use to keep leverage low, even through the now expanded build out of the Conway facility. Despite the macroeconomic environment, we were able to successfully execute on both. First, we have a world-class lending syndicate who worked with us to develop a covenant package better suited for the opportunities we're trying to capitalize on in our Conway facility within the accelerated window in which they were being presented. We then were able to raise approximately 119 million through the sale of common stock at $10 per share, our go-public price. We raised 69 million from two existing Westrock Coffee investors, Haslam family and Brown Brothers Harriman, which we took as a strong vote of confidence in our team, our strategy, and how we have gone about executing that strategy. We also raised 50 million from two new investors who were excited for the opportunity to partner with us as we grow our business. The expansion of our extracts and our RTD business in Conway is the gateway to future EBITDA expansion and remains our top strategic priority and key enabler of future growth. The equity investments and credit agreement amendment form part of a capital plan that ensures the complete build out of the now expanded Conway facility and allows us to remain active as we look for other opportunities to grow the business. Shifting to our second quarter results, total company net sales for the second quarter were 224.7 million compared to 223.4 million for the second quarter of 2022. Consolidated top line momentum was driven by 11% sales growth in beverage solutions, which was partially offset by a 33% decrease in net sales in sustainable sourcing and traceability. Gross profit, excluding the impact of mark-to-market adjustments, decreased 5.6 million to 34.7 million due to a combination of one-time cost associated with our ERP conversion, one-time cost associated with the rapid scale up of our single-serve platform, and higher coffee and production labor cost in beverage solutions compared to the prior year quarter. Consolidated adjusted EBITDA was 11.3 million compared to 13.3 million for the second quarter of 2022. On a segment basis, our beverage solution segment contributed 189.7 million of net sales for the second quarter of 2023, which represents year-over-year growth of 11%. Adjusted EBITDA for the second quarter of 2023 was 11.7 million, compared to 12.5 million for the prior year second quarter. Overall, our beverage solution segment benefited from 51% growth in the sales of flavors, extracts and ingredient products year-over-year and although we did not see the economic benefits of our growth in single-serve volume in our second quarter, we feel confident that the operational improvements are in place to drive improved financial performance from this platform in the back half of the year. Turning to our SS&T segment, sales net of inter-segment revenues were 35 million during the second quarter of 2023, a decrease of 33% compared to the second quarter of 2022, which was driven by lower sales volume as global coffee roasters continue to roast through their buffer stock and we experienced an unfavorable sales mix. Adjusted EBITDA for the quarter was negative 400,000 compared to positive 800,000 for the prior year second quarter. With respect to capital expenditures, during the second quarter, we deployed approximately 35 million of CapEx, primarily related to our Conway extract and RTD facility. And at quarter end, we had approximately 120 million of consolidated unrestricted cash and undrawn revolving credit commitments. Our consolidated net leverage ratio at June 30 was 4.9 times based on LTM adjusted EBITDA, but if you take into account the aggregate gross proceeds from our equity raise, which closed earlier this month, our consolidated net leverage ratio at June 30 would have been 2.7 times based on LTM adjusted EBITDA. We believe these investments provide sufficient liquidity to achieve our near-term growth targets and capital expenditure needs. Turning to our outlook for 2023, today, we are reaffirming the guidance we provided in late June for adjusted EBITDA to reflect flat to up 10% growth over 2022. As we look to the back half of 2023, there are several headwinds that are now behind us. The first is our ERP conversion, which collectively cost us $4 million to $5 million in gross profit in the first half of the year. These costs will be out of our run rate for the second half of 2023. Secondly, the operational challenges of scaling up our single-server platform and the related cost, which cost us approximately 4 million in the first half of 2023, are largely behind us. These costs will be out of our run rate in the second half of 2023 as well. In addition, in the back half of 2023, we will benefit from new sales coming online, improved operational efficiencies throughout our manufacturing operation, and pricing improvements, which help offset higher material and labor costs we experienced over the past four quarters. Finally, we expect to see improvement in our SS&T segment, as sales volume and sales mix return to more normal levels. Just a reminder that this guidance is an estimate of what the company believes is realizable, as of the date of this call, and actual results may vary from this guidance, and the variations may be material. With that, I'll hand the call back over to Scott for a few closing remarks.